Besides tumour cells, CD99 antigen is also expressed on the surface of leukocytes population (CD45+), thus for the analysis of β3-Ars expression on EWS tumour cells it was necessary to evidence the CD45+ population to deplete it and enrich for CD45− CD99+ tumour cells. This evidence concerns the gene CD99 and neoplasm.